Paul Tudor Jones’s Insmed INSM Stock Holding History

Paul Tudor Jones’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$842K	Buy	7,900 +600	+8%	+$72.7K	﹤0.01%	2533
2026 Q1	$1.19M	Sell	7,300 -35,800	-83%	-$5.5M	﹤0.01%	2232
2025 Q4	$7.5M	Buy	43,100 +17,700	+70%	+$3.23M	0.01%	907
2025 Q3	$3.66M	Buy	25,400 +20,400	+408%	+$2.5M	0.01%	1406
2025 Q2	$503K	Sell	5,000 -2,500	-33%	-$191K	﹤0.01%	2598
2025 Q1	$572K	Sell	7,500 -13,000	-63%	-$994K	﹤0.01%	2197
2024 Q4	$1.42M	Buy	20,500 +6,000	+41%	+$432K	0.01%	1483
2024 Q3	$1.06M	Buy	+14,500	New	+$1.07M	﹤0.01%	1581

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Paul Tudor Jones's INSM Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Insmed (INSM) in Q2 2026: 195,391 shares worth $20.8M. The stake represents 0.03% of the portfolio and ranks #467 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in INSM as recently as Q3 2025.

Paul Tudor Jones first reported a position in INSM in Q1 2015 and has held it in 28 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Paul Tudor Jones held 195,391 shares of Insmed worth $20.8M as of Q2 2026.
Insmed was a new Paul Tudor Jones position in Q2 2026.
Insmed made up 0.03% of Paul Tudor Jones's portfolio in Q2 2026, its #467 holding.
Paul Tudor Jones first reported a position in Insmed in Q1 2015 and has held it in 28 quarters since.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.